![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: GAS8 |
Gene summary for GAS8 |
![]() |
Gene information | Species | Human | Gene symbol | GAS8 | Gene ID | 2622 |
Gene name | growth arrest specific 8 | |
Gene Alias | CILD33 | |
Cytomap | 16q24.3 | |
Gene Type | protein-coding | GO ID | GO:0000003 | UniProtAcc | A0A087WZT7 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
2622 | GAS8 | LZE4T | Human | Esophagus | ESCC | 3.56e-06 | 1.14e-01 | 0.0811 |
2622 | GAS8 | LZE7T | Human | Esophagus | ESCC | 6.97e-03 | 2.09e-01 | 0.0667 |
2622 | GAS8 | LZE20T | Human | Esophagus | ESCC | 3.62e-02 | 8.40e-02 | 0.0662 |
2622 | GAS8 | LZE24T | Human | Esophagus | ESCC | 1.61e-09 | 2.53e-01 | 0.0596 |
2622 | GAS8 | P1T-E | Human | Esophagus | ESCC | 2.40e-02 | 2.20e-01 | 0.0875 |
2622 | GAS8 | P2T-E | Human | Esophagus | ESCC | 6.10e-20 | 2.05e-01 | 0.1177 |
2622 | GAS8 | P4T-E | Human | Esophagus | ESCC | 3.67e-05 | 9.17e-02 | 0.1323 |
2622 | GAS8 | P5T-E | Human | Esophagus | ESCC | 5.09e-19 | 1.85e-01 | 0.1327 |
2622 | GAS8 | P8T-E | Human | Esophagus | ESCC | 1.76e-16 | 1.80e-01 | 0.0889 |
2622 | GAS8 | P9T-E | Human | Esophagus | ESCC | 8.65e-06 | 8.42e-02 | 0.1131 |
2622 | GAS8 | P10T-E | Human | Esophagus | ESCC | 2.31e-11 | 7.42e-02 | 0.116 |
2622 | GAS8 | P11T-E | Human | Esophagus | ESCC | 2.97e-10 | 3.05e-01 | 0.1426 |
2622 | GAS8 | P12T-E | Human | Esophagus | ESCC | 1.49e-20 | 1.28e-01 | 0.1122 |
2622 | GAS8 | P15T-E | Human | Esophagus | ESCC | 4.28e-06 | 8.82e-02 | 0.1149 |
2622 | GAS8 | P16T-E | Human | Esophagus | ESCC | 2.71e-11 | 1.79e-01 | 0.1153 |
2622 | GAS8 | P20T-E | Human | Esophagus | ESCC | 4.33e-11 | 1.86e-01 | 0.1124 |
2622 | GAS8 | P21T-E | Human | Esophagus | ESCC | 9.76e-21 | 2.87e-01 | 0.1617 |
2622 | GAS8 | P22T-E | Human | Esophagus | ESCC | 2.57e-20 | 1.87e-01 | 0.1236 |
2622 | GAS8 | P23T-E | Human | Esophagus | ESCC | 1.12e-18 | 3.80e-01 | 0.108 |
2622 | GAS8 | P24T-E | Human | Esophagus | ESCC | 6.10e-17 | 1.14e-01 | 0.1287 |
Page: 1 2 3 4 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Oral cavity | OSCC | ![]() |
Oral cavity | LP | ![]() |
Oral cavity | EOLP | ![]() |
Oral cavity | NEOLP | ![]() |
Esophagus | HGIN | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0051098111 | Esophagus | ESCC | regulation of binding | 251/8552 | 363/18723 | 6.73e-20 | 8.46e-18 | 251 |
GO:1903829111 | Esophagus | ESCC | positive regulation of cellular protein localization | 199/8552 | 276/18723 | 2.99e-19 | 3.45e-17 | 199 |
GO:004339320 | Esophagus | ESCC | regulation of protein binding | 135/8552 | 196/18723 | 3.69e-11 | 1.22e-09 | 135 |
GO:190382912 | Liver | Cirrhotic | positive regulation of cellular protein localization | 123/4634 | 276/18723 | 4.06e-13 | 3.22e-11 | 123 |
GO:005109812 | Liver | Cirrhotic | regulation of binding | 148/4634 | 363/18723 | 9.14e-12 | 5.97e-10 | 148 |
GO:004339312 | Liver | Cirrhotic | regulation of protein binding | 83/4634 | 196/18723 | 4.44e-08 | 1.42e-06 | 83 |
GO:190382922 | Liver | HCC | positive regulation of cellular protein localization | 199/7958 | 276/18723 | 1.15e-23 | 2.62e-21 | 199 |
GO:005109822 | Liver | HCC | regulation of binding | 225/7958 | 363/18723 | 3.78e-14 | 2.37e-12 | 225 |
GO:004339322 | Liver | HCC | regulation of protein binding | 129/7958 | 196/18723 | 3.27e-11 | 1.26e-09 | 129 |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
GAS8 | SNV | Missense_Mutation | c.247N>A | p.Glu83Lys | p.E83K | O95995 | protein_coding | deleterious(0) | possibly_damaging(0.878) | TCGA-BH-A0EE-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Chemotherapy | docetaxel | SD | |
GAS8 | insertion | Frame_Shift_Ins | novel | c.634_635insCT | p.Glu212AlafsTer12 | p.E212Afs*12 | O95995 | protein_coding | TCGA-A7-A0D9-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | taxotere | SD | ||
GAS8 | insertion | Nonsense_Mutation | novel | c.635_636insAAATCAGTAGTTATCAGCAGGTGGTAGCTATTCAGTGCCGT | p.Glu213AsnfsTer3 | p.E213Nfs*3 | O95995 | protein_coding | TCGA-A7-A0D9-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | taxotere | SD | ||
GAS8 | insertion | Frame_Shift_Ins | novel | c.603_604insAG | p.Leu202SerfsTer22 | p.L202Sfs*22 | O95995 | protein_coding | TCGA-BH-A0B8-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Hormone Therapy | arimidex | SD | ||
GAS8 | insertion | In_Frame_Ins | novel | c.605_606insATCAGCAGGTGGTAGCTATTCAGTGCCGTG | p.Leu202_Arg203insSerAlaGlyGlySerTyrSerValProTrp | p.L202_R203insSAGGSYSVPW | O95995 | protein_coding | TCGA-BH-A0B8-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Hormone Therapy | arimidex | SD | ||
GAS8 | deletion | Frame_Shift_Del | novel | c.1178delA | p.Asn393ThrfsTer7 | p.N393Tfs*7 | O95995 | protein_coding | TCGA-D8-A27V-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Hormone Therapy | tamoxiphen | SD | ||
GAS8 | SNV | Missense_Mutation | rs138136933 | c.674G>A | p.Arg225His | p.R225H | O95995 | protein_coding | tolerated(0.24) | benign(0.42) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
GAS8 | SNV | Missense_Mutation | c.226N>A | p.Glu76Lys | p.E76K | O95995 | protein_coding | tolerated(0.07) | benign(0.432) | TCGA-HM-A4S6-01 | Cervix | cervical & endocervical cancer | Female | <65 | III/IV | Chemotherapy | cisplatin | CR | |
GAS8 | SNV | Missense_Mutation | rs374824417 | c.860N>A | p.Arg287Gln | p.R287Q | O95995 | protein_coding | tolerated(0.89) | benign(0.007) | TCGA-A6-2686-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
GAS8 | SNV | Missense_Mutation | novel | c.472G>A | p.Val158Met | p.V158M | O95995 | protein_coding | tolerated(0.13) | benign(0.03) | TCGA-AA-3845-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | PD |
Page: 1 2 3 4 5 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |